420 with CNW – Cerebral Palsy Added to Michigan Medical Cannabis Qualifying Conditions

Voters approved a ballot measure in 2008 to legalize medical cannabis in Michigan and since then, the list of the qualifying conditions has been expanding slowly. Cerebral palsy is the latest condition to be added onto that list which has just over two dozen health conditions.

LARA (the Department of Licensing and Regulatory Affairs) made the announcement after its sitting to consider the different conditions which had been proposed for inclusion on the list of medical marijuana qualifying conditions. LARA rejected requests to include Chronic Aggressive Behavior among the conditions that can be treated or managed using medical marijuana.

Cerebral palsy, a neurological disorder, develops when the brain of a child gets injured during its developmental stage. Some of the symptoms that can result from this condition are lack of motor function and control. There is evidence that marijuana can help to reduce the spastic movements or the seizures experienced by people suffering from cerebral palsy.

According to the statistics of the United Cerebral Palsy Foundation, about 764,000 people are affected by this disorder in the U.S. Most of those individuals (500,000) are kids that are less than 18 years of age.

It is therefore a big help that cerebral palsy has been added to the list of qualifying conditions in Michigan since conventional medicine offers little help to people suffering from this condition.

It is hoped that more people will now be able to get medical cannabis cards from the state. Currently, 294,000 people are registered and have medical marijuana cards in Michigan.

Accessing the medical marijuana program doesn’t have any age restriction, and many kids with various conditions, such as seizures, are cardholders in the state. The only extra requirements for kids is that a minimum of two doctors should recommend them to start using medical cannabis and the parent or guardian of that minor has to give consent for the child to start taking medical marijuana.

Last year, Michigan voters approved a ballot measure to legalize recreational cannabis. Adult-use cannabis will only be available to those who are at least 21 years old. Plans are underway to set up a regulatory system for the recreational sector, but the medical cannabis program will remain intact.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) and Generation Alpha, Inc. (OTCQB: GNAL) applaud the progressive approach taken by LARA which will allow patients and investors in Michigan to benefit from cannabis as the industry evolves.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Delaware Considers Letting Doctors Prescribe Cannabis for Most Ailments

Senator Anthony Delcollo has introduced a bill in the state senate to change the law so that doctors will be free to decide which patient would be helped by medical marijuana instead of first checking whether that patient has a condition listed in the medical marijuana law.

Under the current law which was passed in 2011, patients can only qualify to get onto the medical marijuana program if they have one of the “debilitating conditions” such as terminal illnesses and cancer.

Delcollo argues that doctors undergo extensive training and have a lot of experience in the field. These professionals should be given the liberty to decide what is in the best interest of their patients, he says.

Senate Bill 24 is therefore intended to free doctors to use their discretion in determining whether medical cannabis will provide “palliative or therapeutic benefit” to patients.

The senator argues that this wouldn’t be a new thing since doctors are already exercising their professional discretion to determine which pharmaceuticals on the market are most likely to be beneficial to their patients.

Medical cannabis advocates concur and say that the proposed change is long overdue. They add that it should have been part of the first law that legalized medical marijuana in the state in 2011.

The bill is also intended to ease the restrictions on the kinds of medical specialists that are authorized to recommend the use of medical cannabis by patients who are younger than 18. However, the change would not alter the current provision stating that patients who are less than 18 can only use cannabis oil and not any other form of medical marijuana.

Senate Bill 24 enjoys bipartisan sponsorship and support, so it is hoped that the lawmakers will debate it thoroughly and give it the nod.

If it passes, Delaware will join Oklahoma and Maine as the only states that give doctors such leeway in deciding who can or cannot be treated using medical marijuana.

It hasn’t been an easy journey for Delaware to get to this point. It should be recalled that there were endless delays in opening the compassion centers where patients could access medical cannabis. To date, only four such centers are operational in the state.

More recently, there were plans to legalize recreational marijuana legislatively. More than a year was taken to debate the bill and when a vote was called, the bill was defeated by just four votes in June last year. No other recreational marijuana bill has yet been tabled during this legislative session.

Be that as it may, Global Payout, Inc. (OTC: GOHE), Golden Developing Solutions, Inc. (OTC: DVLP) and the entire investment community are hoping that this time round, appropriate legislation improving the medical cannabis environment is passed so that all interested parties, such as patients, can benefit.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Georgia House Votes to Allow Medical Cannabis Oil

The Georgia House of Representatives voted last week (March 5) and passed a bill intended to regulate the manufacture and sale of medical marijuana oil. This bill now goes to the state senate for consideration before it becomes law.

The existing regulations in Georgia don’t allow the cultivation, manufacture or sale of cannabis oil, and this has left patients using medical marijuana in the state with no source of cannabis oil even if the laws allow the use of that oil as long as its THC content doesn’t exceed 5 percent.

House Bill 324 is geared at changing that so that patients who enroll on the medical cannabis program can access medical cannabis oil.

Once the bill is enacted into law, the 8,400 patients who have so far registered in the medical cannabis program of the state will be able to buy cannabis oil from one of the 60 medical marijuana dispensaries in the state.

Allan Powell, the Republican chair of the committee that initially considered the bill before sending it to the entire House for a vote, said that he was happy that a legal avenue was being created for qualifying patients to access marijuana oil.

He added that it was hypocritical to pass a law stipulating what kind of cannabis oil patients should use yet no mechanism was put in place to make it possible for patients to access that oil.

House Bill 324 sets the bar high for companies that would like to participate in the medical cannabis industry of the state. For example, large companies will have to pay $150,000 for a license while smaller companies will have to fork out $37,000. It will cost $30,000 to get a license to operate a medical cannabis retail business.

Renewing those licenses will not be any easier either. The fees for this range between $10,000 and $50,000. The businesses had better attract a large volume of sales if they are to thrive despite these high license acquisition and renewal fees.

Meanwhile, the bill still has opposition outside the chambers of the lawmakers. For example, the Georgia Sheriffs’ Association led by Terry Norris has described the bill as something that will take the state down a dangerous and treacherous path that may end into kids using marijuana while adults will eventually switch from cannabis to more dangerous drugs.

Such scaremongering isn’t new, but it may amount to nothing since even the Governor has promised to sign the law once it is passed by the senate. Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) and ChineseInvestors.com (OTCQB: CIIX) hope that the legislation will be passed and implemented expeditiously so that patients and investors don’t have to wait any longer than is necessary for them to access medical cannabis oil or the opportunities the industry offers.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – The UN Announces Yet Another Delay of its Cannabis Reclassification Vote

First, the World Health Organization (“WHO”) delayed and postponed the release of its recommendations after an expert committee studied proposals for the reclassification of cannabis in international treaties. Now, yet another delay has hit that activity and the UN has announced that the March sitting of the UN Commission on Narcotic Drugs, and the one in December this year, will not have marijuana reclassification on its agenda.

The recommendations of WHO had initially been scheduled to be voted on in December last year, but this was inexplicably postponed.

Some of the 53 members of the Narcotic Drugs Commission reportedly claimed that they needed additional time to study the recommendations made by the World Health Organization before they can decide how to vote when a vote is called.

Other members, such as Uruguay and Norway, were disappointed that no timeline was set for when the recommendations will be considered and voted upon. There are fears that the matter may be put on the backburner for an indefinite amount of time, for political reasons.

The recommendations were widely seen as a way for many countries to be free to embark on medical cannabis research and legalization, with others taking it a step further and decriminalizing adult-use marijuana.

The WHO had recommended that whole-plant marijuana and its resin should be removed from the strictest category (Category 4) of the 1961 International Drug Convention and placed in a less restrictive category.

To put this into perspective, the U.S. system of categorizing controlled substances is different from that of the UN. For example, in the U.S., Schedule 1 is reserved for the substances that deserve the strictest controls and the restrictions reduce as the schedule number gets bigger. This is unlike the UN where the smaller numbers have fewer restrictions while the bigger numbers, such as Category 4, have more stringent restrictions.

Meanwhile, as the UN is still playing hide and seek regarding its position on the calls for marijuana rescheduling, Europe is taking a different path. The EU Parliament approved a resolution calling on member states to avail support and funding for medical cannabis research. While the decision isn’t binding, it could pave the way for widespread research and legal reforms in EU member countries. This will leave the U.S. further behind in the rapidly evolving cannabis industry.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) and Earth Science Tech, Inc. (OTCQB: ETST) call on the UN to stop dragging its feet and make the decision for which the world has been waiting.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Montel Williams, Ricki Lake and Henry Rollins to Speak at O’Cannabiz Conference & Expo in Toronto

  • Event slated to include a business conference, industry awards, an industry expo and a public expo
  • Topics include growing and cultivation, cannabis science, health and wellness, and policy and regulations
  • O’Cannabiz Conference & Expo expected to feature more than 120 world-class speakers, 7,000 attendees and 250 exhibitors

O’Cannabiz Conference & Expo will bring together cannabis professionals and industry experts from throughout Canada and around the world on April 25–27 at the International Centre in Toronto. Celebrity speakers will include Montel Williams, Ricki Lake and Henry Rollins. Learn more at www.OCannabiz.com.

Reserve tickets now and register at http://cnw.fm/685Fn.

O’Cannabiz will offer a diverse mix of business conferences, industry awards and industry and public expos. The event is designed to gather together global and Canadian professionals to teach participants about growing cannabis, managing businesses and becoming knowledgeable regarding policy and…

Read More>>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWireText “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Smart Investment Leads to Big Opportunities in Growing Cannabis Market

CannabisNewsWire Editorial Coverage: As the cannabis market grows, companies are seizing the opportunity to make strategic investments in the sector and establish a foothold in the promising space.

  • Cannabis and related products are legal in an ever-increasing number of jurisdictions.
  • Businesses have responded with an increasingly diverse range of products.
  • Companies making the smartest investments, such as carefully selected mergers and acquisitions, are in the best position to profit from this while minimizing risks.

SinglePoint Inc. (OTCQB: SING) (SING Profile) has invested in a number of other cannabis companies to grow its portfolio and leverage its position in the market. Marijuana Company of America Inc. (OTCQB: MCOA) (MCOA Profile), with its hemp-oriented business, is expecting a surge in profits following the crop’s federal legalization in the United States in December. Medical Marijuana Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, has seen record sales. PotNetwork Holdings Inc. (OTC: POTN) is reaching out to new customers with a CBD-infused slushy machine. And American Premium Water Corp. (OTC: HIPH) is also pushing…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – THC may be More Therapeutic than CBD, Study Finds

From the reports in the media and what people discuss, one is led to believe that CBD (cannabidiol) contains all the medicinal benefits in the cannabis plant while THC (tetrahydrocannabinol) symptomizes everything that is bad about cannabis since it is psychoactive. However, the findings of a recent study may turn this popular belief on its head.

According to a study whose findings appeared in the Scientific Reports Journal, THC seems to have a higher link with the relief of disease symptoms when compared to CBD.

The researchers from the University of New Mexico studied the data provided by medical cannabis users in the U.S. regarding various aspects of the medical cannabis that they consumed. The ReLeaf app allows patients to indicate various things, such as what they are suffering from, what marijuana strains they are consuming, how they are consuming that marijuana and what effects they notice after consuming medical cannabis.

The researchers looked at the data and found that the patients who used marijuana strains that had higher levels of THC when compared to the CBD content reported superior symptom relief unlike those patients whose medical marijuana had low levels of THC and higher levels of CBD.

Sarah See Stith, one of the co-authors of the research commented that their study was important in light of the fact that not enough information is given to patients when they want to try medical cannabis for their conditions.

Stith pointed out that almost all patients get a recommendation from a doctor and are on their own in terms of selecting the products to use. Some of those patients rely on their prior experience when they used to consume recreational marijuana. Others talk to family and friends while some go to the internet to educate themselves about medical cannabis. The staff at medical cannabis dispensaries are often poorly trained, so they cannot be relied upon to give dependable advice on the appropriate medical cannabis products for patients.

Stith thinks that their research findings can help to initiate a discussion and further research into how cannabis works to treat or provide symptomatic relief.

This research is also important because it comes at a time when the U.S., the UN and other international bodies are on the verge of deciding whether to reschedule cannabis or leave it in the most restrictive categories of the national/international treaties controlling narcotic substances.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) welcome this research and hope that those findings will be considered by those who formulate cannabis policies and regulations in Washington.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – The NFL Could Change its Cannabis Rules

According to recent media reports, the National Football League (NFL) may be considering changing its substance abuse rules with regard to marijuana. Analysts expect that the NFL may try to use any changes that it makes to its marijuana rules as a negotiating chip during its talks with the NFL players’ union.

A former offensive linesman, Kyle Turley, has also revealed that the NFL is studying the possibility of using cannabis as an alternative to pain killers. Research is being done by the NFL in this regard.

Kyle Turley owns a company that makes CBD supplements for athletes, so he can be expected to have an ear on the ground regarding the developments in the league, especially those developments that may impact his business either positively or adversely.

Roger Goodell, the NFL Commissioner, admitted in January that he had talked to some players’ representatives about marijuana. He added that the medical advisers of the league constantly look at the new research and the available data regarding the effects of cannabis on the players and advise accordingly.

In the past, Goodell was unequivocal in his opposition to the consumption of marijuana in the league. For example, in 2017, the Commissioner told ESPN that ingesting smoke (cannabis) couldn’t in any way be good for an NFL player.

However, recent times have seen a decline in the vigor that the league deploys to enforce its policy on marijuana even if some players have been suspended for testing positive for the substance. Those players were given a chance to return to the league yet previously one would be out for good.

While the news that the NFL may be thinking about changing its policy on cannabis may be good, industry advocates are wondering what the Commissioner and his team have up their sleeves. For example, what kind of concessions do they want to squeeze out of the players’ union in return for altering the policy on cannabis?

What these advocates had expected were statements to the effect that the NFL regrets any past actions that may have driven players into opioid addiction yet cannabis would have saved them and kept them playing. This is exactly what is happening in the states that are legalizing recreational cannabis. There is an admission that the war on drugs meted out untold suffering on sections of the population, and that legalization wants to put that past behind.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and other industry players like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) hope that the NFL changes its cannabis policy for the right reasons, instead of using it as a tool to manipulate the players.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Sector ETFs Provide Diversified Entry Point for Fast-Moving Industries

CannabisNewsWire Editorial Coverage: Individuals hoping to gain exposure to the movement of the markets have two primary options: spend a lot of time and effort researching public companies, or put faith into a fund. A solid investment strategy is key to keeping pace with inflation and reaching your financial goals, but the significant risk and volatility that can come with investing in a small group of companies is a real turn-off for most part-time investors.

Increasingly, novices and seasoned traders alike are turning to mutual funds for their stability and ease of use. According to data from the Investment Company Institute, mutual funds were the most common type of investment company owned in 2018, with 44.8 percent of U.S. households owning shares of mutual funds or similar U.S.-registered investment companies – including exchange-traded funds (ETFs), closed-end funds and unit investment trusts. As Matthew P. Fink notes in The Rise of Mutual Funds: An Insider’s View, “Today U.S. mutual funds are…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Medical Cannabis Bill Passed by Key Kentucky Committee

The House Judiciary Committee in Kentucky voted on Wednesday (March 6) to pass a bill that would legalize medical cannabis in the state. The bill will now be sent to the Rules Committee of the Assembly.

House Bill 136 was co-sponsored by 43 members out of the 100 members in the entire lawmaking chamber. This bill intends to create a Department for Alcoholic Beverage and Cannabis Control. This agency will then design a medical cannabis program for the state.

The agency will also be responsible for giving medical marijuana licences to patients who meet the criteria for such a licence. Healthcare providers, processors, cultivators and dispensaries will also be regulated by this agency.

16 legislators on the House Judiciary Committee voted in favor of the bill while one lawmaker voted against it.

Opinion polls in the state show that 80 percent of all adults think that it is okay to allow patients to have the option of using medical cannabis if their doctors recommend it. Governor Matt Bevin has also expressed his support for medical marijuana.

Despite that support from the public and the Governor, attempts to legalize medical marijuana in the state still have major hurdles to overcome.

For example, Robert Stivers, the Senate President, has been vocal in opposing medical cannabis. He even went as far as comparing it to alcohol, saying that anyone who wanted to feel better or relax can take a glass or bourbon instead of consuming medical marijuana.

The Kentucky Medical Association is also adamant that it will only support medical cannabis legislation once the Food and Drug Administration (FDA) approves the use of medical marijuana.

The sponsors of this legalization bill are aware of this strong opposition and made a number of modifications to the bill in order to build some consensus around it.

For example, the original bill had provisions that would allow patients enrolled on the medical marijuana program to grow a maximum of six mature plants for their own use. This was dropped from the bill.

Another change that was made regarded the qualifying conditions for which a patient could use medical marijuana. Originally, the framers of the bill had wanted doctors to use their discretion to decide which patient would benefit from medical cannabis. The bill was amended to create a specific list of conditions for which patients could be treated using medical marijuana.

It is now up to the Rules Committee to decide whether House Bill 136 can now be put before the entire House for a vote. A decision must be made quickly, since this legislative session only has five more days before it ends.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) hope that the legislators make the best decision within the limited time left so that patients don’t have to wait longer for a treatment option that is already available in other states.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com